Abstract

Thromboembolic prophylaxis of women with mechanical heart valves during pregnancy is best achieved with OA; however, this increases the risk of fetal embryopathy. Substituting OA with heparin between 6 and 12 weeks reduces the risk of fetopathic effects, but with an increased risk of thromboembolic complications. The use of low-dose heparin is definitely inadequate; the use of adjusted-dose heparin warrants aggressive monitoring and appropriate dose adjustment. Large prospective trials to determine the best regimen for these women are needed.

Keywords

MedicinePregnancyAbortionObstetricsWarfarinHeparinRegimenGestationFetusSurgeryInternal medicineAtrial fibrillation

Affiliated Institutions

Related Publications

Publication Info

Year
2000
Type
review
Volume
160
Issue
2
Pages
191-191
Citations
742
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

742
OpenAlex

Cite This

Wee‐Shian Chan, Sonia S. Anand, Jeffrey S. Ginsberg (2000). Anticoagulation of Pregnant Women With Mechanical Heart Valves. Archives of Internal Medicine , 160 (2) , 191-191. https://doi.org/10.1001/archinte.160.2.191

Identifiers

DOI
10.1001/archinte.160.2.191